Global and Japan Oral Hypoglycemic Agents (OHAs) Market Insights, Forecast to 2027

Global and Japan Oral Hypoglycemic Agents (OHAs) Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Oral Hypoglycemic Agents (OHAs) Product Introduction
1.2 Market by Type
1.2.1 Global Oral Hypoglycemic Agents (OHAs) Market Size Growth Rate by Type
1.2.2 Sulfonylureas
1.2.3 Metformin
1.2.4 Thiazolidinediones
1.2.5 Alpha-Glucosidase Inhibitors
1.3 Market by Application
1.3.1 Global Oral Hypoglycemic Agents (OHAs) Market Size Growth Rate by Application
1.3.2 Type 2 Diabetes Mellitus
1.3.3 Type 1 Diabetes Mellitus
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Hypoglycemic Agents (OHAs) Market Size, Estimates and Forecasts
2.1.1 Global Oral Hypoglycemic Agents (OHAs) Revenue 2016-2027
2.1.2 Global Oral Hypoglycemic Agents (OHAs) Sales 2016-2027
2.2 Global Oral Hypoglycemic Agents (OHAs), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Oral Hypoglycemic Agents (OHAs) Historical Market Size by Region (2016-2021)
2.3.1 Global Oral Hypoglycemic Agents (OHAs) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Oral Hypoglycemic Agents (OHAs) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Oral Hypoglycemic Agents (OHAs) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Oral Hypoglycemic Agents (OHAs) Sales Forecast by Region (2022-2027)
2.4.2 Global Oral Hypoglycemic Agents (OHAs) Revenue Forecast by Region (2022-2027)
3 Global Oral Hypoglycemic Agents (OHAs) Competitor Landscape by Players
3.1 Global Top Oral Hypoglycemic Agents (OHAs) Manufacturers by Sales
3.1.1 Global Oral Hypoglycemic Agents (OHAs) Sales by Manufacturer (2016-2021)
3.1.2 Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Oral Hypoglycemic Agents (OHAs) Manufacturers by Revenue
3.2.1 Key Oral Hypoglycemic Agents (OHAs) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Manufacturers (2016-2021)
3.2.3 Global Oral Hypoglycemic Agents (OHAs) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Oral Hypoglycemic Agents (OHAs) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Oral Hypoglycemic Agents (OHAs) Revenue in 2020
3.2.6 Global Oral Hypoglycemic Agents (OHAs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Oral Hypoglycemic Agents (OHAs) Price by Manufacturers
3.4 Global Oral Hypoglycemic Agents (OHAs) Manufacturing Base Distribution, Product Types
3.4.1 Oral Hypoglycemic Agents (OHAs) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Hypoglycemic Agents (OHAs) Product Type
3.4.3 Date of International Manufacturers Enter into Oral Hypoglycemic Agents (OHAs) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Oral Hypoglycemic Agents (OHAs) Market Size by Type (2016-2021)
4.1.1 Global Oral Hypoglycemic Agents (OHAs) Sales by Type (2016-2021)
4.1.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Type (2016-2021)
4.1.3 Oral Hypoglycemic Agents (OHAs) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Oral Hypoglycemic Agents (OHAs) Market Size Forecast by Type (2022-2027)
4.2.1 Global Oral Hypoglycemic Agents (OHAs) Sales Forecast by Type (2022-2027)
4.2.2 Global Oral Hypoglycemic Agents (OHAs) Revenue Forecast by Type (2022-2027)
4.2.3 Oral Hypoglycemic Agents (OHAs) Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Oral Hypoglycemic Agents (OHAs) Market Size by Application (2016-2021)
5.1.1 Global Oral Hypoglycemic Agents (OHAs) Sales by Application (2016-2021)
5.1.2 Global Oral Hypoglycemic Agents (OHAs) Revenue by Application (2016-2021)
5.1.3 Oral Hypoglycemic Agents (OHAs) Price by Application (2016-2021)
5.2 Oral Hypoglycemic Agents (OHAs) Market Size Forecast by Application (2022-2027)
5.2.1 Global Oral Hypoglycemic Agents (OHAs) Sales Forecast by Application (2022-2027)
5.2.2 Global Oral Hypoglycemic Agents (OHAs) Revenue Forecast by Application (2022-2027)
5.2.3 Global Oral Hypoglycemic Agents (OHAs) Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Oral Hypoglycemic Agents (OHAs) Market Size YoY Growth 2016-2027
6.1.1 Japan Oral Hypoglycemic Agents (OHAs) Sales YoY Growth 2016-2027
6.1.2 Japan Oral Hypoglycemic Agents (OHAs) Revenue YoY Growth 2016-2027
6.1.3 Japan Oral Hypoglycemic Agents (OHAs) Market Share in Global Market 2016-2027
6.2 Japan Oral Hypoglycemic Agents (OHAs) Market Size by Players (International and Local Players)
6.2.1 Japan Top Oral Hypoglycemic Agents (OHAs) Players by Sales (2016-2021)
6.2.2 Japan Top Oral Hypoglycemic Agents (OHAs) Players by Revenue (2016-2021)
6.3 Japan Oral Hypoglycemic Agents (OHAs) Historic Market Review by Type (2016-2021)
6.3.1 Japan Oral Hypoglycemic Agents (OHAs) Sales Market Share by Type (2016-2021)
6.3.2 Japan Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Type (2016-2021)
6.3.3 Japan Oral Hypoglycemic Agents (OHAs) Price by Type (2016-2021)
6.4 Japan Oral Hypoglycemic Agents (OHAs) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Oral Hypoglycemic Agents (OHAs) Sales Forecast by Type (2022-2027)
6.4.2 Japan Oral Hypoglycemic Agents (OHAs) Revenue Forecast by Type (2022-2027)
6.4.3 Japan Oral Hypoglycemic Agents (OHAs) Price Forecast by Type (2022-2027)
6.5 Japan Oral Hypoglycemic Agents (OHAs) Historic Market Review by Application (2016-2021)
6.5.1 Japan Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application (2016-2021)
6.5.2 Japan Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Application (2016-2021)
6.5.3 Japan Oral Hypoglycemic Agents (OHAs) Price by Application (2016-2021)
6.6 Japan Oral Hypoglycemic Agents (OHAs) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Oral Hypoglycemic Agents (OHAs) Sales Forecast by Application (2022-2027)
6.6.2 Japan Oral Hypoglycemic Agents (OHAs) Revenue Forecast by Application (2022-2027)
6.6.3 Japan Oral Hypoglycemic Agents (OHAs) Price Forecast by Application (2022-2027)
7 North America
7.1 North America Oral Hypoglycemic Agents (OHAs) Market Size YoY Growth 2016-2027
7.2 North America Oral Hypoglycemic Agents (OHAs) Market Facts & Figures by Country
7.2.1 North America Oral Hypoglycemic Agents (OHAs) Sales by Country (2016-2021)
7.2.2 North America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Oral Hypoglycemic Agents (OHAs) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Oral Hypoglycemic Agents (OHAs) Market Facts & Figures by Region
8.2.1 Asia Pacific Oral Hypoglycemic Agents (OHAs) Sales by Region (2016-2021)
8.2.2 Asia Pacific Oral Hypoglycemic Agents (OHAs) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Oral Hypoglycemic Agents (OHAs) Market Size YoY Growth 2016-2027
9.2 Europe Oral Hypoglycemic Agents (OHAs) Market Facts & Figures by Country
9.2.1 Europe Oral Hypoglycemic Agents (OHAs) Sales by Country (2016-2021)
9.2.2 Europe Oral Hypoglycemic Agents (OHAs) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Oral Hypoglycemic Agents (OHAs) Market Size YoY Growth 2016-2027
10.2 Latin America Oral Hypoglycemic Agents (OHAs) Market Facts & Figures by Country
10.2.1 Latin America Oral Hypoglycemic Agents (OHAs) Sales by Country (2016-2021)
10.2.2 Latin America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Oral Hypoglycemic Agents (OHAs) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Oral Hypoglycemic Agents (OHAs) Market Facts & Figures by Country
11.2.1 Middle East and Africa Oral Hypoglycemic Agents (OHAs) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Oral Hypoglycemic Agents (OHAs) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Oral Hypoglycemic Agents (OHAs) Products Offered
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Description and Business Overview
12.3.3 Bayer Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer Oral Hypoglycemic Agents (OHAs) Products Offered
12.3.5 Bayer Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Corporation Information
12.4.2 Bristol-Myers Squibb Description and Business Overview
12.4.3 Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Novonordisk
12.5.1 Novonordisk Corporation Information
12.5.2 Novonordisk Description and Business Overview
12.5.3 Novonordisk Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Novonordisk Oral Hypoglycemic Agents (OHAs) Products Offered
12.5.5 Novonordisk Recent Development
12.6 Sanofi-Aventis
12.6.1 Sanofi-Aventis Corporation Information
12.6.2 Sanofi-Aventis Description and Business Overview
12.6.3 Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Products Offered
12.6.5 Sanofi-Aventis Recent Development
12.7 Servier
12.7.1 Servier Corporation Information
12.7.2 Servier Description and Business Overview
12.7.3 Servier Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Servier Oral Hypoglycemic Agents (OHAs) Products Offered
12.7.5 Servier Recent Development
12.8 Huadong Medicine
12.8.1 Huadong Medicine Corporation Information
12.8.2 Huadong Medicine Description and Business Overview
12.8.3 Huadong Medicine Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Huadong Medicine Oral Hypoglycemic Agents (OHAs) Products Offered
12.8.5 Huadong Medicine Recent Development
12.9 Wanbang Biopharmaceuticals
12.9.1 Wanbang Biopharmaceuticals Corporation Information
12.9.2 Wanbang Biopharmaceuticals Description and Business Overview
12.9.3 Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Products Offered
12.9.5 Wanbang Biopharmaceuticals Recent Development
12.10 Double-Crane Pharmaceutical
12.10.1 Double-Crane Pharmaceutical Corporation Information
12.10.2 Double-Crane Pharmaceutical Description and Business Overview
12.10.3 Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Products Offered
12.10.5 Double-Crane Pharmaceutical Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Oral Hypoglycemic Agents (OHAs) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Oral Hypoglycemic Agents (OHAs) Products Offered
12.11.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Oral Hypoglycemic Agents (OHAs) Industry Trends
13.2 Oral Hypoglycemic Agents (OHAs) Market Drivers
13.3 Oral Hypoglycemic Agents (OHAs) Market Challenges
13.4 Oral Hypoglycemic Agents (OHAs) Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Hypoglycemic Agents (OHAs) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Oral Hypoglycemic Agents (OHAs) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Sulfonylureas
Table 3. Major Manufacturers of Metformin
Table 4. Major Manufacturers of Thiazolidinediones
Table 5. Major Manufacturers of Alpha-Glucosidase Inhibitors
Table 6. Global Oral Hypoglycemic Agents (OHAs) Market Size Growth Rate by Application (2021-2027) & (K MT)
Table 7. Global Oral Hypoglycemic Agents (OHAs) Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Oral Hypoglycemic Agents (OHAs) Sales by Regions (2016-2021) & (K MT)
Table 9. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Regions (2016-2021)
Table 10. Global Oral Hypoglycemic Agents (OHAs) Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Oral Hypoglycemic Agents (OHAs) Sales Forecast by Region (2022-2027) & (K MT)
Table 12. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Oral Hypoglycemic Agents (OHAs) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Oral Hypoglycemic Agents (OHAs) Sales by Manufacturers (2016-2021) (K MT)
Table 16. Global Oral Hypoglycemic Agents (OHAs) Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Oral Hypoglycemic Agents (OHAs) Manufacturers by Revenue (US$ Million) in 2020
Table 18. Oral Hypoglycemic Agents (OHAs) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Oral Hypoglycemic Agents (OHAs) Revenue Share by Manufacturers (2016-2021)
Table 20. Global Oral Hypoglycemic Agents (OHAs) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Oral Hypoglycemic Agents (OHAs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Hypoglycemic Agents (OHAs) as of 2020)
Table 22. Key Manufacturers Oral Hypoglycemic Agents (OHAs) Price (2016-2021) (USD/MT)
Table 23. Oral Hypoglycemic Agents (OHAs) Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Oral Hypoglycemic Agents (OHAs) Product Type
Table 25. Date of International Manufacturers Enter into Oral Hypoglycemic Agents (OHAs) Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Oral Hypoglycemic Agents (OHAs) Sales by Type (2016-2021) (K MT)
Table 28. Global Oral Hypoglycemic Agents (OHAs) Sales Share by Type (2016-2021)
Table 29. Global Oral Hypoglycemic Agents (OHAs) Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Oral Hypoglycemic Agents (OHAs) Revenue Share by Type (2016-2021)
Table 31. Oral Hypoglycemic Agents (OHAs) Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 32. Global Oral Hypoglycemic Agents (OHAs) Sales Forecast by Type (2022-2027) & (K MT)
Table 33. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Oral Hypoglycemic Agents (OHAs) Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Oral Hypoglycemic Agents (OHAs) Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 37. Global Oral Hypoglycemic Agents (OHAs) Sales by Application (2016-2021) (K MT)
Table 38. Global Oral Hypoglycemic Agents (OHAs) Sales Share by Application (2016-2021)
Table 39. Global Oral Hypoglycemic Agents (OHAs) Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Oral Hypoglycemic Agents (OHAs) Revenue Share by Application (2016-2021)
Table 41. Oral Hypoglycemic Agents (OHAs) Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 42. Global Oral Hypoglycemic Agents (OHAs) Sales Forecast by Application (2022-2027) & (K MT)
Table 43. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Oral Hypoglycemic Agents (OHAs) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Oral Hypoglycemic Agents (OHAs) Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 47. Japan Oral Hypoglycemic Agents (OHAs) Sales (K MT) of Key Companies (2016-2021)
Table 48. Japan Oral Hypoglycemic Agents (OHAs) Sales Share by Company (2016-2021)
Table 49. Japan Oral Hypoglycemic Agents (OHAs) Revenue (US$ Million) by Company (2016-2021)
Table 50. Japan Oral Hypoglycemic Agents (OHAs) Revenue Share by Company (2016-2021)
Table 51. Japan Oral Hypoglycemic Agents (OHAs) Sales (K MT) by Type (2016-2021)
Table 52. Japan Oral Hypoglycemic Agents (OHAs) Sales Share by Type (2016-2021)
Table 53. Japan Oral Hypoglycemic Agents (OHAs) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. Japan Oral Hypoglycemic Agents (OHAs) Price (USD/MT) by Type (2016-2021)
Table 55. Japan Oral Hypoglycemic Agents (OHAs) Sales (K MT) by Type (2022-2027)
Table 56. Japan Oral Hypoglycemic Agents (OHAs) Sales Share by Type (2022-2027)
Table 57. Japan Oral Hypoglycemic Agents (OHAs) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. Japan Oral Hypoglycemic Agents (OHAs) Revenue Share by Type (2022-2027)
Table 59. Japan Oral Hypoglycemic Agents (OHAs) Price (USD/MT) by Type (2022-2027)
Table 60. Japan Oral Hypoglycemic Agents (OHAs) Sales (K MT) by Application (2016-2021)
Table 61. Japan Oral Hypoglycemic Agents (OHAs) Sales Share by Application (2016-2021)
Table 62. Japan Oral Hypoglycemic Agents (OHAs) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. Japan Oral Hypoglycemic Agents (OHAs) Price (USD/MT) by Application (2016-2021)
Table 64. Japan Oral Hypoglycemic Agents (OHAs) Sales (K MT) by Application (2022-2027)
Table 65. Japan Oral Hypoglycemic Agents (OHAs) Sales Share by Application (2022-2027)
Table 66. Japan Oral Hypoglycemic Agents (OHAs) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. Japan Oral Hypoglycemic Agents (OHAs) Revenue Share by Application (2022-2027)
Table 68. Japan Oral Hypoglycemic Agents (OHAs) Price (USD/MT) by Application (2022-2027)
Table 69. North America Oral Hypoglycemic Agents (OHAs) Sales by Country (2016-2021) & (K MT)
Table 70. North America Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country (2016-2021)
Table 71. North America Oral Hypoglycemic Agents (OHAs) Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Oral Hypoglycemic Agents (OHAs) Sales by Region (2016-2021) & (K MT)
Table 74. Asia Pacific Oral Hypoglycemic Agents (OHAs) Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Oral Hypoglycemic Agents (OHAs) Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Region (2016-2021)
Table 77. Europe Oral Hypoglycemic Agents (OHAs) Sales by Country (2016-2021) & (K MT)
Table 78. Europe Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country (2016-2021)
Table 79. Europe Oral Hypoglycemic Agents (OHAs) Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country (2016-2021)
Table 81. Latin America Oral Hypoglycemic Agents (OHAs) Sales by Country (2016-2021) & (K MT)
Table 82. Latin America Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Oral Hypoglycemic Agents (OHAs) Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Oral Hypoglycemic Agents (OHAs) Sales by Country (2016-2021) & (K MT)
Table 86. Middle East and Africa Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Oral Hypoglycemic Agents (OHAs) Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country (2016-2021)
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Business Overview
Table 91. Pfizer Oral Hypoglycemic Agents (OHAs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 92. Pfizer Oral Hypoglycemic Agents (OHAs) Product
Table 93. Pfizer Recent Development
Table 94. GlaxoSmithKline Corporation Information
Table 95. GlaxoSmithKline Description and Business Overview
Table 96. GlaxoSmithKline Oral Hypoglycemic Agents (OHAs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Recent Development
Table 99. Bayer Corporation Information
Table 100. Bayer Description and Business Overview
Table 101. Bayer Oral Hypoglycemic Agents (OHAs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 102. Bayer Product
Table 103. Bayer Recent Development
Table 104. Bristol-Myers Squibb Corporation Information
Table 105. Bristol-Myers Squibb Description and Business Overview
Table 106. Bristol-Myers Squibb Oral Hypoglycemic Agents (OHAs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 107. Bristol-Myers Squibb Product
Table 108. Bristol-Myers Squibb Recent Development
Table 109. Novonordisk Corporation Information
Table 110. Novonordisk Description and Business Overview
Table 111. Novonordisk Oral Hypoglycemic Agents (OHAs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 112. Novonordisk Product
Table 113. Novonordisk Recent Development
Table 114. Sanofi-Aventis Corporation Information
Table 115. Sanofi-Aventis Description and Business Overview
Table 116. Sanofi-Aventis Oral Hypoglycemic Agents (OHAs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 117. Sanofi-Aventis Product
Table 118. Sanofi-Aventis Recent Development
Table 119. Servier Corporation Information
Table 120. Servier Description and Business Overview
Table 121. Servier Oral Hypoglycemic Agents (OHAs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 122. Servier Product
Table 123. Servier Recent Development
Table 124. Huadong Medicine Corporation Information
Table 125. Huadong Medicine Description and Business Overview
Table 126. Huadong Medicine Oral Hypoglycemic Agents (OHAs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 127. Huadong Medicine Product
Table 128. Huadong Medicine Recent Development
Table 129. Wanbang Biopharmaceuticals Corporation Information
Table 130. Wanbang Biopharmaceuticals Description and Business Overview
Table 131. Wanbang Biopharmaceuticals Oral Hypoglycemic Agents (OHAs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 132. Wanbang Biopharmaceuticals Product
Table 133. Wanbang Biopharmaceuticals Recent Development
Table 134. Double-Crane Pharmaceutical Corporation Information
Table 135. Double-Crane Pharmaceutical Description and Business Overview
Table 136. Double-Crane Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 137. Double-Crane Pharmaceutical Product
Table 138. Double-Crane Pharmaceutical Recent Development
Table 139. Guangzhou Pharmaceutical Corporation Information
Table 140. Guangzhou Pharmaceutical Description and Business Overview
Table 141. Guangzhou Pharmaceutical Oral Hypoglycemic Agents (OHAs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 142. Guangzhou Pharmaceutical Product
Table 143. Guangzhou Pharmaceutical Recent Development
Table 144. Oral Hypoglycemic Agents (OHAs) Market Trends
Table 145. Oral Hypoglycemic Agents (OHAs) Market Drivers
Table 146. Oral Hypoglycemic Agents (OHAs) Market Challenges
Table 147. Oral Hypoglycemic Agents (OHAs) Market Restraints
Table 148. Oral Hypoglycemic Agents (OHAs) Customers List
Table 149. Oral Hypoglycemic Agents (OHAs) Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Hypoglycemic Agents (OHAs) Product Picture
Figure 2. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Type in 2020 & 2027
Figure 3. Sulfonylureas Product Picture
Figure 4. Metformin Product Picture
Figure 5. Thiazolidinediones Product Picture
Figure 6. Alpha-Glucosidase Inhibitors Product Picture
Figure 7. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application in 2020 & 2027
Figure 8. Type 2 Diabetes Mellitus
Figure 9. Type 1 Diabetes Mellitus
Figure 10. Oral Hypoglycemic Agents (OHAs) Report Years Considered
Figure 11. Global Oral Hypoglycemic Agents (OHAs) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Oral Hypoglycemic Agents (OHAs) Market Size 2016-2027 (US$ Million)
Figure 13. Global Oral Hypoglycemic Agents (OHAs) Sales 2016-2027 (K MT)
Figure 14. Global Oral Hypoglycemic Agents (OHAs) Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Region (2016-2021)
Figure 16. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Region in 2020
Figure 17. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Region (2016-2021)
Figure 18. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Region in 2020
Figure 19. Global Oral Hypoglycemic Agents (OHAs) Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Oral Hypoglycemic Agents (OHAs) Revenue in 2020
Figure 21. Oral Hypoglycemic Agents (OHAs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Type (2016-2021)
Figure 23. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Type in 2020
Figure 24. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Type (2016-2021)
Figure 25. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Type in 2020
Figure 26. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application (2016-2021)
Figure 27. Global Oral Hypoglycemic Agents (OHAs) Sales Market Share by Application in 2020
Figure 28. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Application (2016-2021)
Figure 29. Global Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Application in 2020
Figure 30. Japan Oral Hypoglycemic Agents (OHAs) Sales Growth Rate 2016-2027 (K MT)
Figure 31. Japan Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. Japan Oral Hypoglycemic Agents (OHAs) Market Share in Global Market 2016-2027
Figure 33. Japan 5 and 10 Largest Oral Hypoglycemic Agents (OHAs) Players Market Share by Revenue in Oral Hypoglycemic Agents (OHAs) in 2020
Figure 34. Japan Oral Hypoglycemic Agents (OHAs) Revenue Share by Type (2016-2021)
Figure 35. Japan Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Japan Oral Hypoglycemic Agents (OHAs) Revenue Share by Application (2016-2021)
Figure 37. Japan Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Oral Hypoglycemic Agents (OHAs) Sales Growth Rate 2016-2021 (K MT)
Figure 39. North America Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country in 2020
Figure 41. North America Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country in 2020
Figure 42. U.S. Oral Hypoglycemic Agents (OHAs) Sales Growth Rate (2016-2021) (K MT)
Figure 43. U.S. Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Oral Hypoglycemic Agents (OHAs) Sales Growth Rate (2016-2021) (K MT)
Figure 45. Canada Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Oral Hypoglycemic Agents (OHAs) Sales Growth Rate 2016-2021 (K MT)
Figure 47. Europe Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Oral Hypoglycemic Agents (OHAs) Sales Market Share by Country in 2020
Figure 49. Europe Oral Hypoglycemic Agents (OHAs) Revenue Market Share by Country in 2020
Figure 50. Germany Oral Hypoglycemic Agents (OHAs) Sales Growth Rate (2016-2021) (K MT)
Figure 51. Germany Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Oral Hypoglycemic Agents (OHAs) Sales Growth Rate (2016-2021) (K MT)
Figure 53. France Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Oral Hypoglycemic Agents (OHAs) Sales Growth Rate (2016-2021) (K MT)
Figure 55. U.K. Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Oral Hypoglycemic Agents (OHAs) Sales Growth Rate (2016-2021) (K MT)
Figure 57. Italy Oral Hypoglycemic Agents (OHAs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Oral Hypoglycemic Agents (OHAs) Sales Growth Rate (2016-2021) (K MT)
Figure 59. Russia Ora

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs